VINCERX PHARMA INC (VINC)

US92731L1061 - Common Stock

0.73  -0.17 (-18.59%)

After market: 0.752 +0.02 (+3.01%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-6-30)
2019
(2019-6-30)
Revenue
0.000.000.000.000.00
Operating Expenses
42.61M71.10M62.66M170.00K0.00
Research and Development
28.97M52.15M40.08M7.12MN/A
Selling, General, and Administrative Expenses
13.64M18.95M22.58M3.60MN/A
Operating Income
-42.61M-71.10M-62.66M-170.00K0.00
Interest Income/Expense
1.25M6.97M23.36M50.00KN/A
Other Income/Expense
1.20M1.24M-10.00KN/AN/A
Non Recurring Items
0.00-2.47MN/AN/AN/A
Income Before Taxes
-40.16M-65.37M-39.31M-120.00K0.00
Income Tax
N/AN/AN/A0.00N/A
Net Income
-40.16M-65.37M-39.31M-120.00K0.00
EBITDA
-42.56M-71.05M-62.63MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-1.89-3.11-2.29-0.070.00
Non GAAP EPS
-1.89-3.12-2.28N/AN/A
 
Statistics

All data in USD

Charts